Key result
Alamandine attenuated ovariectomy-induced osteoporosis and maintained bone strength by promoting osteogenic differentiation via the AMPK/eNOS axis.
Why the study?
Alamandine is a newly characterized renin angiotensin system peptide, but its osteo-preservative effects and underlying mechanisms in postmenopausal osteoporosis were unknown.
Alamandine, a renin-angiotensin system peptide, attenuates ovariectomy-induced osteoporosis by promoting osteogenic differentiation via the AMPK/eNOS axis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for alamandine in osteoporosis; human trials needed before any clinical consideration.
BACKGROUND: Alamandine is a newly characterized peptide of renin angiotensin system. Our study aims to investigate the osteo-preservative effects of alamandine, explore underlying mechanism and bring a potential preventive strategy for postmenopausal osteoporosis in the future. METHODS: An ovariectomy (OVX)-induced rat osteoporosis model was established for in vivo experiments. Micro-computed tomography and three-point bending test were used to evaluate bone strength. Histological femur slices were processed for immunohistochemistry (IHC). Bone turnover markers and nitric oxide (NO) concentrations in serum were determined with enzyme-linked immunosorbent assay (ELISA). The mouse embryo osteoblast precursor (MC3T3-E1) cells were used for in vitro experiments. The cell viability was analysed with a Cell Counting Kit‑8. We performed Alizarin Red S staining and alkaline phosphatase (ALP) activity assay to observe the differentiation status of osteoblasts. Western blotting was adopted to detect the expression of osteogenesis related proteins and AMP-activated protein kinase/endothelial nitric oxide synthase (AMPK/eNOS) in osteoblasts. DAF-FM diacetate was used for semi-quantitation of intracellular NO. RESULTS: In OVX rats, alamandine alleviated osteoporosis and maintained bone strength. The IHC showed alamandine increased osteocalcin and collagen type I α1 (COL1A1) expression. The ELISA revealed alamandine decreased bone turnover markers and restored NO level in serum. In MC3T3-E1 cells, alamandine promoted osteogenic differentiation. Western blotting demonstrated that alamandine upregulated the expression of osteopontin, Runt-related transcription factor 2 and COL1A1. The intracellular NO was also raised by alamandine. Additionally, the activation of AMPK/eNOS axis mediated the effects of alamandine on MC3T3-E1 cells and bone tissue. PD123319 and dorsomorphin could repress the regulating effect of alamandine on bone metabolism. CONCLUSION: Alamandine attenuates ovariectomy-induced osteoporosis by promoting osteogenic differentiation via AMPK/eNOS axis.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2024) studied Ovariectomy-induced osteoporosis (n=40). Alamandine vs. Vehicle (HP-β-CD) or Sham was evaluated on Bone mineral density and bone micro-architecture. Alamandine attenuated ovariectomy-induced osteoporosis and maintained bone strength by promoting osteogenic differentiation via the AMPK/eNOS axis.
Synapse has enriched 10 related papers. Consider them for comparative context: